Start exploring your own markets for free

🚀 Try for Free

/AI Therapeutics
Invite

Pending to review

Not sure yet

Interested

Not interested

Showing 104 companies

Download list

Company
Fit assessment
Description
Subspaces
Tags
HQ Location
Founding Date
Employees
Total Funding Raised
Last Funding Event
Received on

Aqemia effectively utilizes machine learning and quantum algorithms to discover new drug candidates, significantly optimizing the drug discovery process.

AQEMIA is a pharmatech company developing a drug discovery platform to discover new drugs for specific therapeutic targets. Its platform combines quantum-inspired physics and machine learning to scale the drug discovery process, generating a growing pipeline of new drug candidates.
  • Drug Discovery Optimization
Light Search
Paris (France)201951 - 200$109.50MGrant, $7.40M, April 1, 2025
Oct 14, 2024

Every Cure effectively leverages machine learning to discover new drug-disease patterns and expand therapeutic options through drug repurposing.

Developer of an artificial intelligence (AI) medical technology designed to understand repurposed treatments. The company uses AI to identify promising drug repurposing opportunities and create a comprehensive drug repurposing database, structuring it as a biomedical knowledge graph, enabling healthcare professionals to treat their patients more optimally.
  • Drug Repurposing
Light Search
New York (United States)202211 - 50$108.30MGrant, $60.00M, October 9, 2024
Oct 14, 2024

SilicoGenesis leverages advanced machine learning technologies to discover new patterns and expand therapeutic options, optimizing the drug discovery process effectively.

SilicoGenesis is a biotechnology research firm that specializes in developing antibodies. The company was founded in 2021 and is based in Johannesburg, South Africa.
  • Drug Discovery Optimization
Light Search
Johannesburg (South Africa)20211 - 10NA
Oct 14, 2024

Ro5 leverages machine learning to enhance drug discovery, identify patterns, and expand therapeutic options, including drug repurposing efforts for COVID-19.

In the race to end disease and suffering, Ro5 uses artificial intelligence to cut the time and cost of drug discovery and development pipelines . . . and analytical solutions for clinical trials. For more information: www.ro5.ai
  • Drug Repurposing
Light Search
London (United Kingdom)201811 - 50Seed, February 1, 2020
Oct 14, 2024

Keystonemab leverages machine learning to discover complex patterns and expand therapeutic uses of existing drugs, including drug repurposing strategies.

Developer of scientific analytics platform designed to derive key insights from vast amounts of data to make smart project-related decisions. The company's platform leverages real-time scientific information from millions of scientific, clinical, and patent documents using AI to accelerate, enabling users the translate knowledge from actionable insights of publications.
  • Drug Repurposing
Light Search
Almere (Netherlands)20191 - 10NA
Oct 14, 2024

Synsight leverages machine learning and deep learning to discover new patterns and expand therapeutic options, optimizing the drug discovery process.

Sysnsight specializes in molecular modeling, bioinformatic and structural biology fields. It offers high quality services to improve and accelerate research for pharmaceutical and cosmetic industries. Its services is integratable into more important research programs as a CRO such as protein design, diagnostic kit conception or drug discovery.
  • Drug Discovery Optimization
Light Search
Évry-Courcouronnes (France)20131 - 10Acquired by Iktos, July 2024
Oct 14, 2024

Sinopia Biosciences effectively leverages machine learning and multi-omics data to discover new patterns and expand therapeutic options, optimizing the drug discovery process.

Sinopia Biosciences is transforming drug discovery and illness research. For the past thirty years, target-based drug discovery has been the predominant method. However, phenotypic screening has shown greater productivity in the discovery of first-in-class medications due to the fact that the pathogenesis of many diseases is often complex and the etiology of many diseases is unclear.
  • Drug Discovery Optimization
Light Search
San Diego (United States)20141 - 10$16.61MGrant, $2.20M, September 12, 2024
Oct 14, 2024

Applied Discoveries effectively leverages machine learning and pattern discovery to develop new therapeutics, optimizing the drug discovery process.

Applied Discoveries utilizes a proprietary platform for natural compound discovery and small-molecule therapeutic development. The company develops small-molecule therapeutics for biotechnology research and regulatory approval. The company is based in Eugene, Oregon, and was founded in 2022.
  • Drug Discovery Optimization
Light Search
Eugene (United States)20221 - 10NA
Oct 14, 2024

SoftMining effectively leverages machine learning and pattern discovery to expand therapeutics, optimizing the drug discovery process with innovative AI technologies.

SoftMining developed theoretical models for the general applicability of query techniques and semantic analysis. They discovered that two molecules with antitumor activity have entered clinical trials, and a new technique for chemical synthesis on a solid support has been developed.
  • Drug Discovery Optimization
Light Search
Fisciano (Italy)20191 - 10NA
Oct 14, 2024

Metanovas effectively leverages machine learning and AI to enhance drug discovery, pattern discovery, and expand therapeutic options.

Metanovas develops nutraceutical and cosmeceutical products with revolutionary AI technology. The company's product pipeline includes pharmaceuticals, nutritional supplements, functional foods, and cosmetics, providing patients and consumers with better goods. Metanovas alters how science and AI are used to generate health products.
  • Drug Discovery Optimization
  • Biomarker Identification
Light Search
Mountain View (United States)202111 - 50$10.00MSeries A, December 3, 2024
Oct 14, 2024

Use "Get more companies" to continue searching, or run a “Deep Dive” for a comprehensive mapping